This interim analysis indicated that there is no benefit from imaging in the follow-up programme for individuals with high-risk cutaneous malignant melanoma. However, only a few participants have completed the follow-up time of 5 years, and the numerical difference between the study groups in distant metastasis-free survival motivates us to continue the study according to protocol.
[Articles] Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB–C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden
The Lancet Oncology | | Cecilia O Ladjevardi, Ylva Naeser, Ulf Dyrke, Dimitrios Papantoniou, Roger Olofsson Bagge, Nils Elander, Christian Ingvar, Petra Flygare, Cecilia Nilsson, Frida Jakobsson, Katrin Lange-Norström, Anders Sundin, Anders Berglund, Frida Nyberg, Bengt Ahringberg-Kald, Hildur Helgadottir, Gustav Ullenhag
Topics: skin-cancer, clinical-trials, research